Abstract:Background Minimal data exist on anticoagulation use and timing and the dose of heparin in patients with sepsis, and whether heparin use improves sepsis survival remains largely unclear. This study was performed to assess whether heparin administration would provide a survival advantage in critically ill patients with sepsis. Methods A retrospective cohort study of patients with sepsis in the Medical Information Mart for Intensive Care (MIMIC)-IV database was conducted. Cox proportional hazards model and propensity score matching (PSM) were used to evaluate the outcomes of prophylactic anticoagulation with heparin administered by subcutaneous injection within 48 h of intensive care unit (ICU) admission. The primary outcome was in-hospital mortality. Secondary outcomes included 60-day mortality, length of ICU stay, length of hospital stay and incidence of acute kidney injury (AKI) on day 7. E-Value analysis were used for unmeasured confounding. Results A total of 6646 adult septic patients were included and divided into an early prophylactic heparin group (n = 3211) and a nonheparin group (n = 3435). In-hospital mortality in the heparin therapy group was significantly lower than that in the nonheparin group (prematched 14.7 vs 20.0%, hazard ratio (HR) 0.77, 95% confidence interval (CI) [0.68-0.87], p < 0.001, and postmatched 14.9 vs 18.3%, HR 0.78, 95% CI [0.68-0.89], p < 0.001). Secondary endpoints, including 60-day mortality and length of ICU stay, differed between the heparin and nonheparin groups (p < 0.01). Early prophylactic heparin administration was associated with in-hospital mortality among septic patients in different adjusted covariates (HR 0.71-0.78, p < 0.001), and only administration of five doses of heparin was associated with decreased in-hospital mortality after PSM (HR 0.70, 95% CI 0.56-0.87, p < 0.001). Subgroup analysis showed that heparin use was significantly associated with reduced in-hospital mortality in patients with sepsis-induced coagulopathy, septic shock, sequential organ failure assessment score >= 10, AKI, mechanical ventilation, gram-positive bacterial infection and gram-negative bacterial infection, with HRs of 0.74, 0.70, 0.58, 0.74, 0.73, 0.64 and 0.72, respectively (p <0.001). E-Value analysis suggested robustness to unmeasured confounding. Conclusions This study found an association between early administration prophylactic heparin provided to patients with sepsis and reduced risk-adjusted mortality. A prospective randomized-controlled study should be designed to further assess the relevant findings.

Curative effect evaluation on low molecular heparin in sepsis patients with acute kidney injury

Efficacy analysis of high-flux hemofiltration in the treatment of sepsis

Can Heparin Therapy Reduce 28-Day Mortality in Adult Severe Sepsis Patients?

Relationship between low molecular weight heparin calcium therapy and prognosis in severe acute kidney injury in sepsis: Mendelian randomized analysis and retrospective study

Effect of the Intensity of Continuous Renal Replacement Therapy in Patients with Sepsis and Acute Kidney Injury: a Single-Center Randomized Clinical Trial

Impact of early heparin therapy on mortality in critically ill patients with sepsis associated acute kidney injury: a retrospective study from the MIMIC-IV database

Clinical Study of Low Molecular Weight Heparin Therapy for Sepsis

Assessment of the Significance of Cysteine Proteinase Inhibitor C and Β2 Microgiobulin in the Diagnosis and Prognosis of Sepsis-Induced Acute Kidney Injury

Effects of Continuous Plasma Adsorption combined with Plasma Filtration Therapy on Immune Function and Prognosis in Patients with Acute Kidney Injury Induced by Sepsis

Relationship between the Cystatin C and the Severity of the Acute Kidney Injury in Patients with Sepsis.

Protocol for a Prospective Observational Study on the Association of Variables Obtained by Contrast-Enhanced Ultrasonography and Sepsis-Associated Acute Kidney Injury

Effect of Low Molecular Weight Heparin on Chinese Patients with Sepsis:A Meta-analysis

Effect of Angiotensin-Converting Enzyme Inhibitor on Acute Kidney Injury in Patients with Sepsis

Effectiveness of continuous plasma filtration combined with plasma adsorption for the septic acute kidney injury

The study of Ulinastatin's curative effect for the patient with sepsis after hepatobiliary surgery

The Therapeutic Effects of Curcumin in Early Septic Acute Kidney Injury: An Experimental Study

Heparin Attenuates Histone-Mediated Cytotoxicity in Septic Acute Kidney Injury

Removal of inflammatory factors and prognosis of patients with septic shock complicated with acute kidney injury by hemodiafiltration combined with HA330‐II hemoperfusion

The Relationship Between Acute Kidney Injury in Sepsis Patients and Coagulation Dysfunction and Prognosis

The clinical study of continuous renal replacement therapy in the treatment of severe sepsis complicated with acute kidney injury

Early Prophylactic Anticoagulation with Heparin Alleviates Mortality in Critically Ill Patients with Sepsis: a Retrospective Analysis from the MIMIC-IV Database